Sunflower oil ( DrugBank: Sunflower oil )

3 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1
240	Phenylketonuria	1
299	Cystic fibrosis	1

46. Malignant rheumatoid arthritis

Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01742468 (ClinicalTrials.gov)	February 2013	3/12/2012	Intervention With Long-chain n-3 Polyunsaturated Fatty Acids From Microalgae Oil in Patients With Rheumatoid Arthritis	Intervention With Products Enriched With Long Chain n-3 Polyunsaturated Fatty Acids (n-3 LC-PUFA) From Microalgae Oil in Patients With Rheumatoid Arthritis - Influence on Disease Activity and Inflammation Status	Rheumatoid Arthritis	Dietary Supplement: long-chain n-3 PUFA;Dietary Supplement: sunflower oil	University of Jena	German Federal Ministry of Education and Research	Completed	40 Years	80 Years	Both	38	N/A	Germany

Clinical trials : 138 / Drugs : 106 - (DrugBank : 11) / Drug target gene : 1 - Drug target pathways : 5

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00909012 (ClinicalTrials.gov)	May 2009	22/4/2009	Quantitative Requirements of Docosahexaenoic Acid for Neural Function in Children With Phenylketonuria	Quantitative Requirements of Docosahexaenoic Acid for Neural Function in Children With Phenylketonuria	Phenylketonuria	Dietary Supplement: high oleic sunflower oil;Dietary Supplement: microalgal oil	Ludwig-Maximilians - University of Munich	European Union	Completed	5 Years	13 Years	All	114	N/A	Germany;Italy;Spain;United Kingdom

Clinical trials : 1,696 / Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02690857 (ClinicalTrials.gov)	May 2010	16/2/2016	Study of Docosahexanoic Acid in Patients With Cystic Fibrosis (CF)	Efficacy of Docosahexanoic Acid on Lipid Peroxidation in Subjects With Cystic Fibrosis	Cystic Fibrosis	Drug: Docosahexaenoic acid;Drug: Sunflower Oil	Hospices Civils de Lyon	NULL	Completed	6 Years	30 Years	Male	10	Phase 2	NULL